Experts encourage prostate cancer patients to weigh long-term impact of treatment options with their doctors

For men with early stage prostate cancer, there is no difference in mortality rates following active monitoring, surgery or RT, ten-year findings from a trial indicate. Moreover, cancer-specific deaths at ten years following diagnosis averaged only one percent for all men enrolled in the trial.